Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models

Authors

Václav Havel, Columbia University
Amanda Hunkele, Washington University School of Medicine in St. Louis
Rohini S Ople, Washington University School of Medicine in St. Louis
Susruta Majumdar, Washington University School of Medicine in St. Louis
et al.

Journal

Nature Communications

Publication Date

9-20-2024

Volume

15

Issue

1

First Page

8118

Document Type

Open Access Publication

DOI

10.1038/s41467-024-51856-y

Rights and Permissions

Havel, V., Kruegel, A.C., Bechand, B. et al. Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models. Nat Commun 15, 8118 (2024). https://doi.org/10.1038/s41467-024-51856-y This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Havel, Václav; Hunkele, Amanda; Ople, Rohini S; Majumdar, Susruta; and et al., "Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models." Nature Communications. 15, 1. 8118 (2024).
https://digitalcommons.wustl.edu/oa_4/4223

Additional Links

Supplemental material is available for this article at publisher site.